Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) Other Non Operating Income: 2023-2025

Historic Other Non Operating Income for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to $1.6 million.

  • Compass Therapeutics' Other Non Operating Income fell 11.38% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 26.94%. This contributed to the annual value of $7.2 million for FY2024, which is 7.87% down from last year.
  • Latest data reveals that Compass Therapeutics reported Other Non Operating Income of $1.6 million as of Q3 2025, which was up 31.48% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Compass Therapeutics' Other Non Operating Income peaked at $2.1 million during Q2 2023, and registered a low of $1.2 million during Q2 2025.
  • In the last 3 years, Compass Therapeutics' Other Non Operating Income had a median value of $1.9 million in 2023 and averaged $1.7 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first rose by 5.82% in 2024, then crashed by 39.82% in 2025.
  • Compass Therapeutics' Other Non Operating Income (Quarterly) stood at $2.0 million in 2023, then fell by 22.09% to $1.5 million in 2024, then dropped by 11.38% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $1.2 million for Q2 2025, and $1.3 million during Q1 2025.